{"id":"W4415899361","doi":"10.1016/j.euo.2025.10.010","title":"Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Abiraterone; Prostate cancer; Placebo; Olaparib; Prostate-specific antigen; Biomarker; Population","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002880415,0.0007479281,0.001705512,0.0004994562,0.0001518146,0.000633843,0.0006717152,0.0007082499,0.004385983],"category_scores_gemma":[0.00339996,0.0003521974,0.001679968,0.000477197,0.0005740895,0.0006864027,0.0004387786,0.001707514,0.0003506653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006364757,"about_ca_system_score_gemma":0.0008755219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003625607,"about_ca_topic_score_gemma":0.0008572086,"domain_scores_codex":[0.9985246,0.001014409,0.00007714468,0.0001197692,0.0001575175,0.000106621],"domain_scores_gemma":[0.9977964,0.001030104,0.0006232784,0.0001133363,0.0001267114,0.0003102513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9582794,0.003636649,0.002039918,0.0007426365,0.001251773,0.0000616327,0.00005164714,0.0007257354,0.004479398,0.00006030796,0.0003591053,0.02831173],"study_design_scores_gemma":[0.5185128,0.4459143,0.0248329,0.0001267003,0.002637746,0.0002232079,0.00007051361,0.00162686,0.00386265,0.0003433135,0.001811926,0.00003707152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922096,0.004137324,0.0003557178,0.0002592925,0.0000844696,0.0008786368,0.0009447804,0.00003899781,0.001091306],"genre_scores_gemma":[0.9953745,0.0009754282,0.0006595431,0.000165278,0.0001273414,0.0009557548,0.000776602,0.000008459058,0.0009572599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004385983,"threshold_uncertainty_score":0.01523322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09922039059211404,"score_gpt":0.4154966879285947,"score_spread":0.3162762973364807,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}